A048: Effects of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: a clinical experience trial

• Published in: American journal of hypertension Vol. 13; no. S2; p. 128A
• Main Authors: Weir, M.R., Weber, M.A., Neutel, J.M., Vendetti, J., Harris, S., Michelson, E.L., Wang, R.
• Format: Journal Article
• Language: English
• Published: Oxford Oxford University Press 01.04.2000
• Subjects: add-on; angiotensin receptor blocker; Candesartan cilexetil; hypertension

Many patients with hypertension (HBP) require more than one agent for effective BP control. This 8-week, multicenter, open-label, not placebo-controlled, single-arm, practice-based trial evaluated the use of candesartan cilexetil (CC) 16 mg titrated to 32 mg as needed for BP control, either alone or...